Suppr超能文献

休克初始治疗期间的平均灌注压不足——一项观察性队列研究。

Mean perfusion pressure deficit during the initial management of shock--an observational cohort study.

机构信息

Department of Anaesthesia, Intensive Care and Pain Medicine, John Hunter Hospital, Newcastle 2305, Australia.

出版信息

J Crit Care. 2013 Oct;28(5):816-24. doi: 10.1016/j.jcrc.2013.05.009. Epub 2013 Jul 10.

Abstract

PURPOSE

It is unclear if blood pressure targets for patients with shock should be adjusted to pre-morbid levels. We aimed to investigate mean deficit between the achieved mean perfusion pressure (MPP) in vasopressor-treated patients and their estimated basal (resting) MPP, and assess whether MPP deficit has any association with subsequent acute kidney injury (AKI).

MATERIALS AND METHODS

Fifty-one consecutive, non-trauma patients, aged ≥40 years, with ≥2 organ dysfunction and requiring vasopressor≥4 hours were observed at an academic intensive care unit. Mean MPP deficit [=%(basal MPP-achieved MPP)/basal MPP] and % time spent with >20% MPP deficit were assessed during initial 72 vasopressor hours (T0-T72) for each patient.

RESULTS

Achieved MPP was unrelated to basal MPP (P=.99). Mean MPP deficit was 18% (95% CI 15-21). Patients spent 48% (95% CI 39-57) time with >20% MPP deficit. Despite similar risk scores at T0, subsequent AKI (≥2 RIFLE class increase from T0) occurred more frequently in patients with higher (>median) MPP deficit compared to patients with lower MPP deficit (56% vs 28%; P=.045). Incidence of subsequent AKI was also higher among patients who spent greater % time with >20% MPP deficit (P=.04).

CONCLUSIONS

Achieved blood pressure during vasopressor therapy had no relationship to the pre-morbid basal level. This resulted in significant and varying degree of relative hypotension (MPP deficit), which could be a modifiable risk factor for AKI in patients with shock.

摘要

目的

目前尚不清楚休克患者的血压目标是否应调整至发病前水平。我们旨在研究血管加压素治疗患者的平均灌注压(MPP)与估计基础(休息时)MPP 之间的平均差值,并评估 MPP 差值是否与随后发生的急性肾损伤(AKI)有关。

材料和方法

在一家学术性重症监护病房观察了 51 例连续的、非创伤性、年龄≥40 岁、有≥2 个器官功能障碍和需要血管加压素≥4 小时的患者。在每个患者的最初 72 小时血管加压素治疗期间(T0-T72),评估初始 MPP 差值[=(基础 MPP-达到的 MPP)/基础 MPP]和有>20%MPP 差值的时间百分比。

结果

达到的 MPP 与基础 MPP 无关(P=.99)。平均 MPP 差值为 18%(95%CI 15-21)。患者有 48%(95%CI 39-57)的时间有>20%MPP 差值。尽管 T0 时的风险评分相似,但与 MPP 差值较低的患者相比,MPP 差值较高(>中位数)的患者随后发生 AKI(从 T0 开始≥2 RIFLE 分级增加)的频率更高(56%比 28%;P=.045)。有更多时间有>20%MPP 差值的患者发生随后 AKI 的发生率也更高(P=.04)。

结论

血管加压素治疗期间达到的血压与发病前的基础水平无关。这导致了相当程度的相对低血压(MPP 差值),这可能是休克患者 AKI 的一个可改变的危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验